Vascular Guidewires Market Size (2024 - 2029)

The vascular guidewires market is projected to experience growth over the forecast period, driven by an increasing prevalence of cardiovascular and neurovascular diseases, a shift towards minimally invasive surgical procedures, and advancements in guidewire technology. Despite an initial decline due to the pandemic, the demand for vascular surgeries has risen, contributing to market expansion. Ongoing research and development efforts are further enhancing market competitiveness and growth potential. However, the market's growth may be challenged by a rising number of product recalls.

Market Size of Vascular Guidewires Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Vascular Guidewires Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 5.20 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Vascular Guidewires Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Vascular Guidewires Market Analysis

The vascular guidewires market is expected to register a CAGR of 5.2% over the forecast period.

Due to the sudden onset of the pandemic, a short-term negative impact was initially seen on the market, owing to the decreased patient visits to hospitals and clinics. However, surgical procedures increased due to the high burden of cardiovascular and other vascular diseases among the target population during the later phases of the pandemic. Also, as per a research study published in the National Library of Medicine in December 2021, severe coronavirus disease 2019 has been complicated by coagulopathy and thrombotic events like venous thromboembolism, pulmonary embolism, and arterial thrombus at a rate higher than has typically been seen with sepsis-induced coagulopathy or disseminated intravascular coagulation leading most centers to treat hospitalized patients with prophylactic anticoagulation. Hence, even though the market experienced a setback initially, there was an increase in the need for vascular surgeries and procedures. 

Factors such as a rising cardiovascular disease burden, growing preference for minimally invasive surgeries, and technological advancements in guidewires are anticipated to fuel the market growth during the forecast period.

The rise in vascular disease and the availability of technologically advanced products with better performance and clinical significance coupled with the prevalence of neurovascular diseases are among the factors accelerating the market expansion. For instance, as per the 2023 data update by Cedars-Sinai, neurovascular disorders, including aneurysms and carotid artery disease create a huge healthcare burden on Americans every year. In addition, as per the same source, every year brain aneurysms affect nearly 6 million Americans, especially people under the age of 50 years. Guidewires allow vascular diagnosis by catheterization and injection of drug fluids into the patient. Hence, the increase in target disease globally is anticipated to create demand for advanced treatment further garnering the overall market growth.

Furthermore, the ongoing research studies is also contributing to the market growth. For instance, in April 2022, MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation successfully completed its first enrollment in a multi-center, prospective EU observational study called STRAIT and reported an excellent performance of the Traxcess EX Guidewire along with a few other vascular devices. Insights on such developments are expected to generate competitiveness in the market and drive future growth.

However, an increasing number of product recalls are predicted to hinder the market's growth over the analysis period.

Vascular Guidewires Industry Segmentation

As per the scope of the report, vascular guidewires are found to be thin tubes made of medical grade, which are inserted in the body, especially in the veins, to perform surgeries or treat chronic diseases. Basically, these tubes or medical devices allow the administration of gases, access to surgical instruments, and drainage, along with performing various tasks depending on the patient's condition. The Vascular Guidewires Market is Segmented by Product (Peripheral Guidewires, Coronary Guidewires, Urology Guidewires and Neurovascular Guidewires), Coating (Coated and Non-coated), Raw Material (Nitinol, Stainless Steel and Other Raw Materials), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Peripheral Guidewires
Coronary Guidewires
Urology Guidewires
Neurovascular Guidewires
By Coating
Coated
Non-coated
By Raw Material
Nitinol
Stainless Steel
Other Raw Materials
By End User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Vascular Guidewires Market Size Summary

The vascular guidewires market is poised for steady growth, driven by an increasing prevalence of cardiovascular diseases and a rising preference for minimally invasive surgical procedures. Despite an initial setback due to the pandemic, which reduced patient visits to healthcare facilities, the demand for vascular surgeries surged as complications from COVID-19, such as coagulopathy and thrombotic events, necessitated more interventions. Technological advancements in guidewire products have further propelled market expansion, offering improved performance and clinical outcomes. The market is also benefiting from ongoing research and development efforts, with companies like MicroVention, Inc. conducting studies to enhance the efficacy of vascular devices. However, the market faces challenges from product recalls, which could impede growth.

North America dominates the vascular guidewires market, supported by a high prevalence of chronic diseases and a robust pipeline of product approvals. The region's market growth is bolstered by strategic initiatives from key players, including product innovations and geographical expansions. Companies such as OpSens Inc. and Boston Scientific Corporation are actively launching new products to meet the growing demand for guidewires in vascular procedures. The competitive landscape is characterized by the presence of both global and regional players, with strategies like partnerships and mergers being employed to strengthen market positions. As the burden of cardiovascular diseases continues to rise, the demand for advanced guidewire solutions is expected to increase, further driving market growth.

Explore More

Vascular Guidewires Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Cardiovascular Disease Burden

      2. 1.2.2 Growing Preference for Minimally Invasive Surgeries

      3. 1.2.3 Technological Advancements in Guidewires

    3. 1.3 Market Restraints

      1. 1.3.1 Increasing Number of Product Recalls

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Peripheral Guidewires

      2. 2.1.2 Coronary Guidewires

      3. 2.1.3 Urology Guidewires

      4. 2.1.4 Neurovascular Guidewires

    2. 2.2 By Coating

      1. 2.2.1 Coated

      2. 2.2.2 Non-coated

    3. 2.3 By Raw Material

      1. 2.3.1 Nitinol

      2. 2.3.2 Stainless Steel

      3. 2.3.3 Other Raw Materials

    4. 2.4 By End User

      1. 2.4.1 Hospitals

      2. 2.4.2 Ambulatory Surgical Centers

      3. 2.4.3 Others

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Vascular Guidewires Market Size FAQs

The Vascular Guidewires Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)

Boston Scientific Corporation, Stryker Corporation, Terumo Medical Corporation, Abbott Laboratories and B. Braun Melsungen AG are the major companies operating in the Vascular Guidewires Market.

Vascular Guidewires Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)